Page 1,662«..1020..1,6611,6621,6631,664..1,6701,680..»

Molecular evolution – Wikipedia

Posted: October 23, 2016 at 11:42 pm

Molecular evolution is the process of change in the sequence composition of cellular molecules such as DNA, RNA, and proteins across generations. The field of molecular evolution uses principles of evolutionary biology and population genetics to explain patterns in these changes. Major topics in molecular evolution concern the rates and impacts of single nucleotide changes, neutral evolution vs. natural selection, origins of new genes, the genetic nature of complex traits, the genetic basis of speciation, evolution of development, and ways that evolutionary forces influence genomic and phenotypic changes.

The content and structure of a genome is the product of the molecular and population genetic forces which act upon that genome. Novel genetic variants will arise through mutation and will spread and be maintained in populations due to genetic drift or natural selection.

Mutations are permanent, transmissible changes to the genetic material (DNA or RNA) of a cell or virus. Mutations result from errors in DNA replication during cell division and by exposure to radiation, chemicals, and other environmental stressors, or viruses and transposable elements. Most mutations that occur are single nucleotide polymorphisms which modify single bases of the DNA sequence, resulting in point mutations. Other types of mutations modify larger segments of DNA and can cause duplications, insertions, deletions, inversions, and translocations.

Most organisms display a strong bias in the types of mutations that occur with strong influence in GC-content. Transitions (A G or C T) are more common than transversions (purine (adenine or guanine)) pyrimidine (cytosine or thymine, or in RNA, uracil))[1] and are less likely to alter amino acid sequences of proteins.

Mutations are stochastic and typically occur randomly across genes. Mutation rates for single nucleotide sites for most organisms are very low, roughly 109 to 108 per site per generation, though some viruses have higher mutation rates on the order of 106 per site per generation. Among these mutations, some will be neutral or beneficial and will remain in the genome unless lost via genetic drift, and others will be detrimental and will be eliminated from the genome by natural selection.

Because mutations are extremely rare, they accumulate very slowly across generations. While the number of mutations which appears in any single generation may vary, over very long time periods they will appear to accumulate at a regular pace. Using the mutation rate per generation and the number of nucleotide differences between two sequences, divergence times can be estimated effectively via the molecular clock.

Recombination is a process that results in genetic exchange between chromosomes or chromosomal regions. Recombination counteracts physical linkage between adjacent genes, thereby reducing genetic hitchhiking. The resulting independent inheritance of genes results in more efficient selection, meaning that regions with higher recombination will harbor fewer detrimental mutations, more selectively favored variants, and fewer errors in replication and repair. Recombination can also generate particular types of mutations if chromosomes are misaligned.

Gene conversion is a type of recombination that is the product of DNA repair where nucleotide damage is corrected using an homologous genomic region as a template. Damaged bases are first excised, the damaged strand is then aligned with an undamaged homolog, and DNA synthesis repairs the excised region using the undamaged strand as a guide. Gene conversion is often responsible for homogenizing sequences of duplicate genes over long time periods, reducing nucleotide divergence.

Genetic drift is the change of allele frequencies from one generation to the next due to stochastic effects of random sampling in finite populations. Some existing variants have no effect on fitness and may increase or decrease in frequency simply due to chance. "Nearly neutral" variants whose selection coefficient is close to a threshold value of 1 / the effective population size will also be affected by chance as well as by selection and mutation. Many genomic features have been ascribed to accumulation of nearly neutral detrimental mutations as a result of small effective population sizes.[2] With a smaller effective population size, a larger variety of mutations will behave as if they are neutral due to inefficiency of selection.

Selection occurs when organisms with greater fitness, i.e. greater ability to survive or reproduce, are favored in subsequent generations, thereby increasing the instance of underlying genetic variants in a population. Selection can be the product of natural selection, artificial selection, or sexual selection. Natural selection is any selective process that occurs due to the fitness of an organism to its environment. In contrast sexual selection is a product of mate choice and can favor the spread of genetic variants which act counter to natural selection but increase desirability to the opposite sex or increase mating success. Artificial selection, also known as selective breeding, is imposed by an outside entity, typically humans, in order to increase the frequency of desired traits.

The principles of population genetics apply similarly to all types of selection, though in fact each may produce distinct effects due to clustering of genes with different functions in different parts of the genome, or due to different properties of genes in particular functional classes. For instance, sexual selection could be more likely to affect molecular evolution of the sex chromosomes due to clustering of sex specific genes on the X,Y,Z or W.

Selection can operate at the gene level at the expense of organismal fitness, resulting in a selective advantage for selfish genetic elements in spite of a host cost. Examples of such selfish elements include transposable elements, meiotic drivers, killer X chromosomes, selfish mitochondria, and self-propagating introns. (See Intragenomic conflict.)

Genome size is influenced by the amount of repetitive DNA as well as number of genes in an organism. The C-value paradox refers to the lack of correlation between organism 'complexity' and genome size. Explanations for the so-called paradox are two-fold. First, repetitive genetic elements can comprise large portions of the genome for many organisms, thereby inflating DNA content of the haploid genome. Secondly, the number of genes is not necessarily indicative of the number of developmental stages or tissue types in an organism. An organism with few developmental stages or tissue types may have large numbers of genes that influence non-developmental phenotypes, inflating gene content relative to developmental gene families.

Neutral explanations for genome size suggest that when population sizes are small, many mutations become nearly neutral. Hence, in small populations repetitive content and other 'junk' DNA can accumulate without placing the organism at a competitive disadvantage. There is little evidence to suggest that genome size is under strong widespread selection in multicellular eukaryotes. Genome size, independent of gene content, correlates poorly with most physiological traits and many eukaryotes, including mammals, harbor very large amounts of repetitive DNA.

However, birds likely have experienced strong selection for reduced genome size, in response to changing energetic needs for flight. Birds, unlike humans, produce nucleated red blood cells, and larger nuclei lead to lower levels of oxygen transport. Bird metabolism is far higher than that of mammals, due largely to flight, and oxygen needs are high. Hence, most birds have small, compact genomes with few repetitive elements. Indirect evidence suggests that non-avian theropod dinosaur ancestors of modern birds [3] also had reduced genome sizes, consistent with endothermy and high energetic needs for running speed. Many bacteria have also experienced selection for small genome size, as time of replication and energy consumption are so tightly correlated with fitness.

Transposable elements are self-replicating, selfish genetic elements which are capable of proliferating within host genomes. Many transposable elements are related to viruses, and share several proteins in common.

DNA transposons are cut and paste transposable elements which excise DNA and move it to alternate sections of the genome.

non-LTR retrotransposons

LTR retrotransposons

Helitrons

Alu elements comprise over 10% of the human genome. They are short non-autonomous repeat sequences.

The number of chromosomes in an organism's genome also does not necessarily correlate with the amount of DNA in its genome. The ant Myrmecia pilosula has only a single pair of chromosomes[4] whereas the Adders-tongue fern Ophioglossum reticulatum has up to 1260 chromosomes.[5]Cilliate genomes house each gene in individual chromosomes, resulting in a genome which is not physically linked. Reduced linkage through creation of additional chromosomes should effectively increase the efficiency of selection.

Changes in chromosome number can play a key role in speciation, as differing chromosome numbers can serve as a barrier to reproduction in hybrids. Human chromosome 2 was created from a fusion of two chimpanzee chromosomes and still contains central telomeres as well as a vestigial second centromere. Polyploidy, especially allopolyploidy, which occurs often in plants, can also result in reproductive incompatibilities with parental species. Agrodiatus blue butterflies have diverse chromosome numbers ranging from n=10 to n=134 and additionally have one of the highest rates of speciation identified to date.[6]

Different organisms house different numbers of genes within their genomes as well as different patterns in the distribution of genes throughout the genome. Some organisms, such as most bacteria, Drosophila, and Arabidopsis have particularly compact genomes with little repetitive content or non-coding DNA. Other organisms, like mammals or maize, have large amounts of repetitive DNA, long introns, and substantial spacing between different genes. The content and distribution of genes within the genome can influence the rate at which certain types of mutations occur and can influence the subsequent evolution of different species. Genes with longer introns are more likely to recombine due to increased physical distance over the coding sequence. As such, long introns may facilitate ectopic recombination, and result in higher rates of new gene formation.

In addition to the nuclear genome, endosymbiont organelles contain their own genetic material typically as circular plasmids. Mitochondrial and chloroplast DNA varies across taxa, but membrane-bound proteins, especially electron transport chain constituents are most often encoded in the organelle. Chloroplasts and mitochondria are maternally inherited in most species, as the organelles must pass through the egg. In a rare departure, some species of mussels are known to inherit mitochondria from father to son.

New genes arise from several different genetic mechanisms including gene duplication, de novo origination, retrotransposition, chimeric gene formation, recruitment of non-coding sequence, and gene truncation.

Gene duplication initially leads to redundancy. However, duplicated gene sequences can mutate to develop new functions or specialize so that the new gene performs a subset of the original ancestral functions. In addition to duplicating whole genes, sometimes only a domain or part of a protein is duplicated so that the resulting gene is an elongated version of the parental gene.

Retrotransposition creates new genes by copying mRNA to DNA and inserting it into the genome. Retrogenes often insert into new genomic locations, and often develop new expression patterns and functions.

Chimeric genes form when duplication, deletion, or incomplete retrotransposition combine portions of two different coding sequences to produce a novel gene sequence. Chimeras often cause regulatory changes and can shuffle protein domains to produce novel adaptive functions.

De novo origin. Novel genes can also arise from previously non-coding DNA.[7] For instance, Levine and colleagues reported the origin of five new genes in the D. melanogaster genome from noncoding DNA.[8][9] Similar de novo origin of genes has been also shown in other organisms such as yeast,[10] rice[11] and humans.[12] De novo genes may evolve from transcripts that are already expressed at low levels.[13] Mutation of a stop codon to a regular codon or a frameshift may cause an extended protein that includes a previously non-coding sequence.

Molecular systematics is the product of the traditional fields of systematics and molecular genetics. It uses DNA, RNA, or protein sequences to resolve questions in systematics, i.e. about their correct scientific classification or taxonomy from the point of view of evolutionary biology.

Molecular systematics has been made possible by the availability of techniques for DNA sequencing, which allow the determination of the exact sequence of nucleotides or bases in either DNA or RNA. At present it is still a long and expensive process to sequence the entire genome of an organism, and this has been done for only a few species. However, it is quite feasible to determine the sequence of a defined area of a particular chromosome. Typical molecular systematic analyses require the sequencing of around 1000 base pairs.

Depending on the relative importance assigned to the various forces of evolution, three perspectives provide evolutionary explanations for molecular evolution.[14]

Selectionist hypotheses argue that selection is the driving force of molecular evolution. While acknowledging that many mutations are neutral, selectionists attribute changes in the frequencies of neutral alleles to linkage disequilibrium with other loci that are under selection, rather than to random genetic drift.[15] Biases in codon usage are usually explained with reference to the ability of even weak selection to shape molecular evolution.[16]

Neutralist hypotheses emphasize the importance of mutation, purifying selection, and random genetic drift.[17] The introduction of the neutral theory by Kimura,[18] quickly followed by King and Jukes' own findings,[19] led to a fierce debate about the relevance of neodarwinism at the molecular level. The Neutral theory of molecular evolution proposes that most mutations in DNA are at locations not important to function or fitness. These neutral changes drift towards fixation within a population. Positive changes will be very rare, and so will not greatly contribute to DNA polymorphisms.[20] Deleterious mutations will also not contribute very much to DNA diversity because they negatively affect fitness and so will not stay in the gene pool for long.[21] This theory provides a framework for the molecular clock.[20] The fate of neutral mutations are governed by genetic drift, and contribute to both nucleotide polymorphism and fixed differences between species.[22][23]

In the strictest sense, the neutral theory is not accurate.[24] Subtle changes in DNA very often have effects, but sometimes these effects are too small for natural selection to act on.[24] Even synonymous mutations are not necessarily neutral [24] because there is not a uniform amount of each codon. The nearly neutral theory expanded the neutralist perspective, suggesting that several mutations are nearly neutral, which means both random drift and natural selection is relevant to their dynamics.[24] The main difference between the neutral theory and nearly neutral theory is that the latter focuses on weak selection, not strictly neutral.[21]

Mutationists hypotheses emphasize random drift and biases in mutation patterns.[25] Sueoka was the first to propose a modern mutationist view. He proposed that the variation in GC content was not the result of positive selection, but a consequence of the GC mutational pressure.[26]

Protein evolution describes the changes over time in protein shape, function, and composition. Through quantitative analysis and experimentation, scientists have strived to understand the rate and causes of protein evolution. Using the amino acid sequences of hemoglobin and cytochrome c from multiple species, scientists were able to derive estimations of protein evolution rates. What they found was that the rates were not the same among proteins.[21] Each protein has its own rate, and that rate is constant across phylogenies (i.e., hemoglobin does not evolve at the same rate as cytochrome c, but hemoglobins from humans, mice, etc. do have comparable rates of evolution.). Not all regions within a protein mutate at the same rate; functionally important areas mutate more slowly and amino acid substitutions involving similar amino acids occurs more often than dissimilar substitutions.[21] Overall, the level of polymorphisms in proteins seems to be fairly constant. Several species (including humans, fruit flies, and mice) have similar levels of protein polymorphism.[20]

Protein evolution is inescapably tied to changes and selection of DNA polymorphisms and mutations because protein sequences change in response to alterations in the DNA sequence. Amino acid sequences and nucleic acid sequences do not mutate at the same rate. Due to the degenerate nature of DNA, bases can change without affecting the amino acid sequence. For example, there are six codons that code for leucine. Thus, despite the difference in mutation rates, it is essential to incorporate nucleic acid evolution into the discussion of protein evolution. At the end of the 1960s, two groups of scientistsKimura (1968) and King and Jukes (1969)-- independently proposed that a majority of the evolutionary changes observed in proteins were neutral.[20][21] Since then, the neutral theory has been expanded upon and debated.[21]

There are sometimes discordances between molecular and morphological evolution, which are reflected in molecular and morphological systematic studies, especially of bacteria, archaea and eukaryotic microbes. These discordances can be categorized as two types: (i) one morphology, multiple lineages (e.g. morphological convergence, cryptic species) and (ii) one lineage, multiple morphologies (e.g. phenotypic plasticity, multiple life-cycle stages). Neutral evolution possibly could explain the incongruences in some cases.[27]

The Society for Molecular Biology and Evolution publishes the journals "Molecular Biology and Evolution" and "Genome Biology and Evolution" and holds an annual international meeting. Other journals dedicated to molecular evolution include Journal of Molecular Evolution and Molecular Phylogenetics and Evolution. Research in molecular evolution is also published in journals of genetics, molecular biology, genomics, systematics, and evolutionary biology.

Continue reading here:
Molecular evolution - Wikipedia

Posted in Molecular Genetics | Comments Off on Molecular evolution – Wikipedia

Bone Marrow or Stem Cell Transplant – New Hampshire

Posted: October 23, 2016 at 11:41 pm

What is a bone marrow or stem cell transplant?

A bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) is a treatment for some types of cancer and bone marrow problems. Bone marrow is spongy tissue in the center of many bones. It makes red blood cells, white blood cells, and platelets. Red blood cells carry oxygen from the lungs and bring the oxygen to the rest of the body. White blood cells fight infections. Platelets are necessary for blood to clot.

Stem cells are young blood cells in the bone marrow that can become red blood cells, white blood cells, or platelets. Most bone marrow stem cells are in the marrow, but some are in the bloodstream. Blood in the human newborn umbilical cord also contains stem cells. Stem cells can be obtained from any of these sources for use in transplants.

A bone marrow or stem cell transplant may be done to:

A common reason for the use of stem cell transplants in cancer treatment is to make it possible for you to have very high doses of chemotherapy or total-body radiation therapy. These treatments destroy cancer cells throughout the body, but they also destroy normal bone marrow and stem cells. A stem cell transplant right after high-dose chemotherapy and radiation helps your body have healthy bone marrow again. The transplanted cells go to the bone marrow and become the new stem cells, replacing the stem cells that were destroyed by treatment. Your body can then make the blood cells you need.

Stem cell transplants are most often used in the treatment of 3 types of cancer: leukemia, myeloma, and lymphoma. Stem cell transplants are also used to treat other cancers, such as testicular cancer. Researchers are studying stem cell transplants to see if they will help with other diseases.

Follow all of the instructions provided by your healthcare provider. If you need to take a medicine before donating stem cells, take the medicine exactly as prescribed. If you are to have general anesthesia for the collection of bone marrow cells, eat a light meal, such as soup or salad, the night before the procedure. Do not eat or drink anything after midnight and the morning before the procedure. Do not even drink coffee, tea, or water.

Plan for your care and recovery after the procedure, especially if you are to have general anesthesia. Arrange to have someone take you home and stay with you for a while after the procedure. Allow for time to rest. Try to find people to help you with your daily duties for 24 hours after the procedure

First the bone marrow or stem cells must be collected, which is called harvesting. You may be able to donate your own bone marrow or stem cells; in this case, you are your own donor. Or someone else may donate cells that you will then receive as a transplant.

If you are going to use your own marrow as a transplant, the marrow is harvested before you have chemotherapy or radiation treatment. The marrow is usually collected from the hipbones with a needle. This is done under regional or general anesthesia at the hospital. A regional anesthetic numbs part of your body, preventing you from feeling pain while you remain awake. A general anesthetic puts you to sleep and prevents you from feeling pain while some of the marrow is removed. The procedure for harvesting the marrow takes about an hour.

Stem cells may be harvested from the blood rather than the hipbone. This is called a peripheral blood stem cell transplant. The stem cells can be collected from a donor or from your own blood before you have chemotherapy or radiation therapy. Before the stem cells are collected from your blood, you may be given medicine for a few days to stimulate the production and release of stem cells from the marrow into the bloodstream. This increases the number of stem cells that can be harvested from the blood. The blood is obtained through a large vein in your arm or through a tube placed in a vein in your neck, chest, or groin. The blood goes through a machine that removes the stem cells. The blood is then returned to the donor and the stem cells that were removed from the blood are stored. The collection of the stem cells from the blood takes about 4 to 6 hours. It can be done at an outpatient clinic. Stem cells can be frozen until they are needed.

When it is time for the transplant, the bone marrow or stem cells are given through a vein (IV), like a blood transfusion. The transplant takes 1 to 5 hours.

After you donate bone marrow, the area where the marrow was taken out may feel stiff or sore for a few days, and you may feel tired. Within a few weeks, your body will replace the donated marrow. Some people are back to their usual routine within 2 or 3 days, but others may need 3 to 4 weeks to fully recover their strength.

If you donated stem cells from your blood, you may have some side effects from the medicine used to stimulate the release of stem cells from the marrow into the bloodstream. Possible side effects include fever, bone and muscle aches, headaches, fatigue, nausea, vomiting, and trouble sleeping. These side effects generally go away in 2 to 3 days after the last dose of the medicine.

When you are given a transplant, the stem cells will travel to the bone marrow inside your bones. The cells will begin to make new, healthy blood cells in 2 to 4 weeks. Until the stem cells start to produce new blood cells, you will have a higher risk for infection and bleeding. You may also have a reaction to the transplanted cells if they are not your own. During this time, precautions are taken to prevent infections until your bone marrow can produce enough white blood cells. You may be given platelets to prevent or control any bleeding and antibiotics to prevent or treat infection. You may also be given transfusions of red blood cells to treat severe anemia.

After the transplant, you will have frequent blood tests to see how well your bone marrow is making new blood cells. You may also have a test called bone marrow aspiration, which is the removal of a small sample of bone marrow through a needle for examination under a microscope. This helps your provider see how well your bone marrow is producing new cells and platelets.

Although your body will start making new blood cells in 2 to 4 weeks, it will take much longer for your immune system to completely recover. It could take up to several months if your own stem cells are used and 1 to 2 years if the stem cells were donated by someone else.

When used as a part of the treatment for cancer or other diseases, a stem cell transplant makes it possible for you to receive very high doses of chemotherapy or radiation therapy. The transplant can restore your ability to make new, healthy blood cells and to fight disease.

When you donate bone marrow, there are usually no serious risks other than the risks of the general or regional anesthesia used during the procedure. You should discuss the risks of anesthesia with your healthcare provider. There is no risk from anesthesia when stem cells are harvested from the blood because anesthesia is not needed.

When you receive a stem cell transplant:

You should ask your healthcare provider how these risks apply to you.

Call your provider right away if:

For more information about bone marrow transplants, contact:

Disclaimer: This content is reviewed periodically and is subject to change as new health information becomes available. The information provided is intended to be informative and educational and is not a replacement for professional medical evaluation, advice, diagnosis or treatment by a healthcare professional.

HIA File hemo3503.htm Release 13/2010

2010 RelayHealth and/or its All rights reserved.

Excerpt from:
Bone Marrow or Stem Cell Transplant - New Hampshire

Posted in New Hampshire Stem Cells | Comments Off on Bone Marrow or Stem Cell Transplant – New Hampshire

CFR-Trilateral pedophile Jeffrey Epsteins corporate …

Posted: October 22, 2016 at 6:44 pm

Jeffrey Epstein is currently infamous for his conviction for soliciting a fourteen-year-old girl for prostitution and for allegedly orchestrating underage sex slave orgies at his private Virgin Island mansion, where he purportedly pimped out underage girls to elite political figures such as Prince Andrew, Alan Dershowitz, and probably Bill Clinton as well (he also traveled to Thailand in 2001 with Prince Andrew, probably to indulge in the countrys rampant child sex trade).

But before these sex scandals were the highlight of Epsteins celebrity, he was better known not just for his financial prowess, but also for his extensive funding of biotechnological and evolutionary science. With his bankster riches, he founded the Jeffrey Epstein VI Foundation which established Harvard Universitys Program for Evolutionary Dynamics.

Epstein, a former CFR and Trilateral Commission Member, also sat on the board of Harvards Mind, Brain, and Behavior Committee. He has furthermore been actively involved in . . . the Theoretical Biology Initiative at the Institute for Advanced Study at Princeton, the Quantum Gravity Program at the University of Pennsylvania, and the Santa Fe Institute, which is a transdisciplinary research community that expands the boundaries of scientific understanding . . . to discover, comprehend, and communicate the common fundamental principles in complex physical, computational, biological, and social systems.

The scope of Epsteins various science projects spans research into genetics, neuroscience, robotics, computer science, and artificial intelligence (AI). Altogether, the convergence of these science subfields comprises an interdisciplinary science known as transhumanism: the artificial perfection of human evolution through humankinds merger with technology. In fact, Epstein partners with Humanity+, a major transhumanism interest group.

Transhumanists believe that technologically upgrading humankind into a singularity will bring about a utopia in which poor health, the ravages of old age and even death itself will all be things of the past. In fact, eminent transhumanist Ray Kurzweil, chief of engineering at Google, believes that he will become godlike as a result of the singularity.

But the truth is that transhumanism is merely a more high-tech revision of eugenics conceptualized by eugenicist and UNESCO Director-General Julian Huxley. And when corporate philanthropists like pedophile Epsteinas well as Bill Gates, Mark Zuckerberg, Peter Thiel, and Google executives such as Eric Schmidt and Larry Pageare the major bankrollers behind these transhumanism projects, the whole enterprise seems ominously reminiscent of the corporate-philanthropic funding of American and Nazi eugenics.

In America, Charles Davenports eugenics research at Cold Spring Harbor was bankrolled by elite financiers, such as the Harriman family, as well as robber barons and their nonprofit foundations such as the Rockefeller Foundation and the Carnegie Institute of Washington. Davenport collaborated with Nazi eugenicists who were likewise funded by the Rockefeller Foundation. In the end, these Rockefeller-funded eugenics programs contributed to the forced sterilization of over 60,000 Americans and the macabre human experimentation and genocide of the Nazi concentration camps. (This sinister collusion is thoroughly documented in War Against the Weak by award-winning investigative journalist Edwin Black).

If history has shown us that these are the sordid bioethics that result from corporate-funded biosocial science, shouldnt we be weary of the transhumanism projects of neo-robber barons like Epstein, Gates, Zuckerberg, Thiel, and the Google gang?

It should be noted that Epstein once sat on the board of Rockefeller University. At the same time, the Rockefeller Foundationwhich has continued to finance Cold Spring Harbor programs as recently as 2010also funds the Santa Fe Institute and the New York Academy of Sciences, both of which Epstein has been actively involved in.

The Rockefeller Foundation also funds the Malthusian-eugenic Population Council, which transhumanist Bill Gates likewise finances in carrying on the population reduction activism of his father, William H. Gates Sr.

And in 2013, the Rockefeller Foundation funded a transhumanistic white paper titled Dreaming the Future of Health for the Next 100 Years, which explores [r]e-engineering of humans into separate and unequal forms through genetic engineering or mixed human-robots.

So, considering that transhumanismthe outgrowth of eugenicsis being steered not only by twenty-first-century robber barons, but by corporatist monopoly men who are connected to the very transhumanist Rockefeller Foundation which funded Nazi eugenics, I suspect that transhumanist technology will not upgrade the common person. Rather, it will only be disseminated to the public in such a wayas Stanford University Professor Paul Saffo predictsthat converts social class hierarchies into bio(techno)logical hierarchies by artificially evolving the One Percent into a species separate from the unfit working poor, which will be downgraded as a slave class.

In his 1932 eugenic-engineering dystopia, Brave New World, Aldous Huxley (Julians brother) depicts how biotechnology, drugs, and psychological conditioning would in the future be used to establish a Scientific Caste System ruled by a global scientific dictatorship. But Huxley was not warning us with his novel. As historian Joanne Woiak demonstrates in her journal article entitled Designing a Brave New World: Eugenics, Politics, and Fiction, Aldous brave new world can . . . be understood as a serious design for social reform (105). In a 1932 essay, titled Science and Civilization, Huxley promoted his eugenic caste system: in a scientific civilization society must be organized on a caste basis. The rulers and their advisory experts will be a kind of Brahmins controlling, in virtue of a special and mysterious knowledge, vast hordes of the intellectual equivalents of Sudras and Untouchables (153-154).

With the aforementioned digital robber barons driving the burgeoning age of transhumanist neo-eugenics, I fear that Huxleys Scientific Caste System may become a reality. And with Epstein behind the wheel, the new GMO Sudras will likely consist of not only unskilled labor slaves, but also child sex slaves wholike the preadolescents in Brave New Worldwill be brainwashed with Elementary Sex Education, which will inculcate them with a smash monogamy sexuality that will serve the elite World Controllers.

References

Huxley, Aldous. Science and Civilization. Aldous Huxley: Complete Essays. Eds. Robert S. Baker and James Sexton. Vol. III. Chicago: Ivan R. Dee, 2000. 148-155. Print. 4 vols.

John Klyczek has an MA in English and is a college English instructor, concentrating on the history of global eugenics and Aldous Huxleys dystopian novel, Brave New World.

Excerpt from:
CFR-Trilateral pedophile Jeffrey Epsteins corporate ...

Posted in Transhumanist | Comments Off on CFR-Trilateral pedophile Jeffrey Epsteins corporate …

Transhumanism – Transhumanismo

Posted: October 22, 2016 at 6:44 pm

-Alguien Quiere Ser Androide? - El Cerebro Puede Sobrevivir a La Muerte del Cuerpo

- Biological Immortality and You

- Cerebros y Mentes Digitales - A La Vuelta de La Esquina

- Chemtrails, Transmutacin Gentica y Transhumanidad

- CYBORG

- Cyborg America - Inside the Strange New World of Basement Body Hackers

- Cyborg Brain/Machine Interface is Now Reality

- DARPA - Defense Advanced Research Projects Agency - Main File

- Depopulation of A Planet - Thinning Out The Useless Eaters - An Unspoken NWO Agenda

- El Movimiento Singularidad, la Inmortalidad y Quitando el 'Fantasma' de La Mquina

- El Programa Inmortalidad 2045' del Transhumanismo Amenaza La Integridad de La Humanidad

- El Reino de Las Mquinas - La Separacin de los Mundos 1

- Ethical Assessment of Implantable Brain Chips

- Ethical Issues in Human Enhancement

- Futurist Claims Technology Causing Humans to 'Evolve' Into a New Species

- 'Genetically Modified Micro Humans' to be 'Farmed' for Drug Testing by 2017 - Mad Science

- Google versus Muerte - El Combate del Siglo?

- Hacking The Human Brain Furthers The Advent of Super Soldiers

- How 'Smart Dust' Could Spy on Your Brain

- Humans Fully Outsourced to Robots by 2045?

- Immortality Transhumanism Program 2045 Threatens Humanitys Integrity

- Intelligent Neural Dust Embedded in The Brain Could Be The Ultimate Brain-Computer Interface

- Is The Transhumanist Movement a Threat to Our Survival?

- Kurzweil and Google Working Together to Develop Technology for Immortality

- La Agenda de Vacunacin - Transhumanismo Implcito

Espaol

- La Fantasa del Transhumanismo es un Fracaso para la Humanidad

Espaol

- La Inmortalidad Digital

- La Trampa del Transhumanismo - Porqu el Hackeo Biolgico Encadena la Conciencia al Mundo Material

- Literal Smart Dust Opens Brain-Computer Pathway to "Spy on Your Brain"

- Merely Human? Thats So Yesterday

- Merging Man and Machine - Singularity vs. Humanity

- Mind-Blowing Benefits of Merging Human Brains and Computers - Hitler Would Have Loved The Singularity

- Nano-Bots, Mind Control and Trans-Humanism - The Future of Consciousness?

- Neo-Humanity - Transhumanism Will Merge Man With Machine

- Neural Dust - An Ultrasonic, Low Power Solution for Chronic BrainMachine Interfaces

- Pentagon Looks to Breed Immortal 'Synthetic Organisms' - Molecular Kill-Switch Included

Espaol

- Por La Senda del Transhumanismo

Espaol

- Revelacin de los Objetivos Transhumanistas de la Elite

- Russian Scientist Says Immortality Possible for Wealthy Elite by 2045

- Scientist Says Immortality Only 20 Years Away

- Signs of a Transhuman Future - The New Technologies that Will Change Human Civilization as We Know It

- Superhuman Powers and Life Extension Technologies will Allow Us to Become Like God - Transhumanists

- 'Super Soldier' - Genetically Modified Humans Won't Need Food, Sleep

- Teilhard de Chardin and Transhumanism

Espaol

- Tecnologas Trans-Humanas - Anticuerpos Plsticos, Impresin de rganos

- The Coming Technological Singularity - How to Survive in The Post-Human Era

Espaol

-Te Gustara Ser como 'Dios'? - Transhumanismo

- The Anatomy of Cyborg Man - Overcoming the Mechanistic Mind

- The Ethics of Transhumanism and The Return of Eugenics

- The Evolution of The Humanoid Robot

- The Human Avatar Programs by NASA & DARPA

- The Looming Future of GMO Technology - Transhumanism, Biocrops, and More

- The Machine Kingdom

- The Singularity - Main File

- The Singularity Movement, Immortality, and Removing the Ghost in The Machine

- The Transhumanism Fantasy is a Failure for Humanity

- The Transhumanism Trap - Why Biohacking Chains Consciousness to the Material World

- The Vaccination Agenda - Implicit Transhumanism

- Top Transhumanism CEO Says Artificial Intelligence Singularity Will Go Very Badly For Humans

- TransEvolution - The Age of Human Deconstruction

- (Trans)humanism and Biopolitics

- Transhumanism Advances With The Creation of GM Babies

- Transhumanist Bankers Plan Robotic Future

- Transhumanism - From MK-Ultra to Google

- Transhumanism - Is a Future Where Men Have Merged With Machines Inevitable?

Espaol

- Transhumanismo - Desde el MK-Ultra hasta Google

Espaol

- Transhumanismo - La Agenda Antihumana del Culto a la 'Singularidad'

- Transhumanism - The Anti-Human Agenda of the 'Singularity' Cult

- Transhumanism - The New Face of Eugenics

Go here to read the rest:
Transhumanism - Transhumanismo

Posted in Transhumanism | Comments Off on Transhumanism – Transhumanismo

What is Integrative Medicine? – Andrew Weil, M.D.

Posted: October 22, 2016 at 6:43 pm

Andrew Weil, M.D., is the worlds leading proponent of alternative medicine, right?

Wrong.

Although this is how the popular media often portrays him, Dr. Weil is actually the worlds leading proponent of integrative medicine, a philosophy that is considerably different from a blanket endorsement of alternative medicine. To fully understand Dr. Weils advice presented in his Web sites, bestselling books and lectures, and reflected in the daily practice of thousands of physicians worldwide its important to grasp what integrative medicine is, and is not.

The first step is mastering some basic terms.

Using synthetic drugs and surgery to treat health conditions was known just a few decades ago as, simply, medicine. Today, this system is increasingly being termed conventional medicine. This is the kind of medicine most Americans still encounter in hospitals and clinics. Often both expensive and invasive, it is also very good at some things; for example, handling emergency conditions such as massive injury or a life-threatening stroke. Dr. Weil is unstinting in his appreciation for conventional medicines strengths. If I were hit by a bus, he says, Id want to be taken immediately to a high-tech emergency room. Some conventional medicine is scientifically validated, some is not.

Any therapy that is typically excluded by conventional medicine, and that patients use instead of conventional medicine, is known as alternative medicine. Its a catch-all term that includes hundreds of old and new practices ranging from acupuncture to homeopathy to iridology. Generally alternative therapies are closer to nature, cheaper and less invasive than conventional therapies, although there are exceptions. Some alternative therapies are scientifically validated, some are not. An alternative medicine practice that is used in conjunction with a conventional one is known as a complementary medicine. Example: using ginger syrup to prevent nausea during chemotherapy. Together, complementary and alternative medicines are often referred to by the acronym CAM.

Enter integrative medicine. As defined by the National Center for Complementary and Alternative Medicine at the National Institutes of Health, integrative medicine combines mainstream medical therapies and CAM therapies for which there is some high-quality scientific evidence of safety and effectiveness.

In other words, integrative medicine cherry picks the very best, scientifically validated therapies from both conventional and CAM systems. In his New York Times review of Dr. Weils latest book, Healthy Aging: A Lifelong Guide to Your Physical and Spiritual Well-Being, Abraham Verghese, M.D., summed up this orientation well, stating that Dr. Weil, doesnt seem wedded to a particular dogma, Western or Eastern, only to the get-the-patient-better philosophy.

So this is a basic definition of integrative medicine. What follows is the complete one, which serves to guide both Dr. Weils work and that of integrative medicine physicians and teachers around the world:

Integrative medicine is healing-oriented medicine that takes account of the whole person (body, mind, and spirit), including all aspects of lifestyle. It emphasizes the therapeutic relationship and makes use of all appropriate therapies, both conventional and alternative.

The principles of integrative medicine:

By Brad Lemley DrWeil.com News

Originally posted here:
What is Integrative Medicine? - Andrew Weil, M.D.

Posted in Integrative Medicine | Comments Off on What is Integrative Medicine? – Andrew Weil, M.D.

Hormone replacement therapy (HRT) – WebMD

Posted: October 22, 2016 at 6:43 pm

If youre looking for relief from menopause symptoms, knowing the pros and cons of hormone replacement therapy (HRT) can help you decide whether its right for you.

HRT (also known as hormone therapy, menopausal hormone therapy, and estrogen replacement therapy) uses female hormones -- estrogen and progesterone -- to treat common symptoms of menopause and aging. Doctors can prescribe it during or after menopause.

After your period stops, your hormone levels fall, causing uncomfortable symptoms like hot flashes and vaginal dryness, and sometimes conditions like osteoporosis. HRT replaces hormones your body no longer makes. Its the most effective treatment for menopause symptoms.

You might think of pregnancy when you think of estrogen. In women of child-bearing age, it gets the uterus ready to receive a fertilized egg. It has other roles, too -- it controls how your body uses calcium, which strengthens bones, and raises good cholesterol in the blood.

If you still have your uterus, taking estrogen without progesterone raises your risk for cancer of the endometrium, the lining of the uterus. Since the cells from the endometrium arent leaving your body during your period any more, they may build up in your uterus and lead to cancer. Progesterone lowers that risk by thinning the lining.

Once you know the hormones that make up HRT, think about which type of HRT you should get:

Estrogen Therapy: Doctors generally suggest a low dose of estrogen for women who have had a hysterectomy, the surgery to remove the uterus. Estrogen comes in different forms. The daily pill and patch are the most popular, but the hormone also is available in a vaginal ring, gel, or spray.

Estrogen/Progesterone/Progestin Hormone Therapy: This is often called combination therapy, since it combines doses of estrogen and progestin, the synthetic form of progesterone. Its meant for women who still have their uterus.

The biggest debate about HRT is whether its risks outweigh its benefits.

Continued here:
Hormone replacement therapy (HRT) - WebMD

Posted in Hormone Replacement Therapy | Comments Off on Hormone replacement therapy (HRT) – WebMD

Hormone Replacement Therapy – What You Need to Know

Posted: October 22, 2016 at 6:43 pm

This material must not be used for commercial purposes, or in any hospital or medical facility. Failure to comply may result in legal action.

What is it? Hormone replacement therapy (HRT) is a treatment for women who have low hormone levels, like a woman going through menopause. HRT is also called estrogen (es-tro-jin) replacement therapy or ERT. With HRT a woman takes estrogen, and often progestin (pro-jes-tin), to help the symptoms caused by low hormone levels in her body.

What are hormones and how do they work?

What are the reasons I may not have enough estrogen?

What are the signs and symptoms of a low estrogen level? You can have physical and emotional changes when your estrogen level is low.

Will HRT help these symptoms? You may choose to take HRT to help or prevent the symptoms of low estrogen. Hot flashes and night sweats will occur less often and may possibly go away if you take estrogen. Estrogen helps prevent vaginal dryness and thinning of the tissue inside the vagina. Your chances of breaking a bone are much lower if you take estrogen. HRT may also improve your mood and memory. HRT may reduce your risk of heart disease.

Is HRT safe?

Are there side effects with HRT? Following are possible side effects of HRT.

How long do I need to take HRT? Bone loss is highest during the early years after menopause. To get the best results, HRT should start soon after the beginning of menopause. You should continue with HRT for at least 7 to 10 years. You and your caregiver can decide how long you should take HRT. You will need long-term treatment if you are trying to prevent heart disease or osteoporosis. Bone loss will begin right away when you stop taking HRT.

How do I take HRT?

Are there other ways to prevent bone loss or heart disease without HRT? Eating foods that are rich in calcium and low in fat is one way to control bone loss and heart disease. Caregivers may give you medicine to prevent bone loss or heart disease. Other ways to prevent bone loss and heart disease are to exercise regularly and to limit the amount of alcohol that you drink. You should not have more than 1 drink a day. A drink is 1 1/2 ounces of whiskey, 5 ounces of wine, or 12 ounces of beer (regular or light). If you smoke, you should quit.

How often should I see my caregiver if I take HRT? Call your caregiver if you are bleeding from your vagina or have other side effects that are bothering you. You should see your caregiver every year for a check up. Your caregiver may want you to have the following tests.

Where can I get more information about HRT? You can call or write the following organizations for more information.

You have the right to help plan your care. To help with this plan you must learn about hormone replacement therapy. You can then discuss the treatment options with caregivers. Work with them to decide what care will be used to treat your decreasing estrogen levels. You always have the right to refuse treatment.

Visit link:
Hormone Replacement Therapy - What You Need to Know

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy – What You Need to Know

Hormone Replacement Therapy – Teresa knight

Posted: October 22, 2016 at 6:43 pm

Lets put menopausal estrogen use in an historical perspective: Throughout history and as women have become over-nourished, the age of puberty has become younger. The age of menopause, however, has stayed the same, on average about 52. When the ancient Egyptians were going through menopause, the average age of death was ten years before menopause. Now the average age of death for women is 78 to 80. We live nearly half our lives past menopause. In the 1960s, scientists discovered hormone replacement and its benefits: improved cognition, less arthritis, stronger bones, better sleep, and better sex.

For decades now, millions of women entering menopause in America were prescribed Premarin or Prempro without much question. Premarin, a mixture of estrogens derived from the urine of a pregnant horse, and Prempro, a combination of horse estrogens and synthetic progesterone, served to replace female hormones that naturally dissipate in peri-menopausal and menopausal women, primarily estrogen and progesterone.

Healthcare providers and their female patients were shocked to learn that hormone replacement therapy was not as safe as they had once thought after receiving the data from the Womens Health Initiative. The results of the study suggested that this type of hormone replacement therapy did not protect a woman from getting heart disease, and actually increased her risk of breast cancer, blood clotting and possible stroke. A reanalysis of this study was completed in 2007 further suggesting that actual heart disease risk factors was dependent upon what age a woman was when she began hormone replacement therapy. These results still remain controversial. Again, in 2008 the study underwent a reanalysis which concluded that hormone therapy is associated with an increased risk of stroke, regardless of when hormone replacement therapy is initiated.

There were major problems with the study. Sponsored by Wyeth, a major producer of HRT, the WHI looked at whether hormone replacement could prevent heart attacks, since estrogen is protective for heart disease. They set up the study as a placebo-control, double-blind study. The problem is, women who are on HRT know it, so they specifically chose women who werent having night sweats or hot flashes. The only women who fit that criterion had an average age of 63, more than 10 years passed menopause. By that age, permanent changes from estrogen deprivation, such as hardening of the arteries, have already occurred. Giving HRT at that point is too late to prevent it and can actually make it worse, so people had more heart attacks and strokes. If supplemention starts early in the mid-40s when menopausal symptoms first start, it has the potential to prevent heart disease. The recent increased concern about HRT is from following women in the original study who were on average ten-plus years beyond menopause, taking oral HRT for at least 15 years, in higher doses than are prescribed today, and taking a combination of estrogen and progestin. Even given that, the increase in breast cancer and death are very slight. None of the non-oral delivery systems or current age and dosage recommendations was studied.

Unfortunately many practitioners often label all hormone replacement therapy the same. What this means is that many women are often advised that the risks apply regardless of the type of hormones. The reality of the study and the reanalysis showed associated risks only for oral conjugated equine estrogens and synthetic progestins, not bio-identical hormones.

Bioidentical, non-oral estrogen supplementation is a different animal. Bioidentical hormones are made in the lab, and once they get into the body, your body recognizes them as their own. The only way that is likely to happen is via a non-oral route. Taking any estrogen orally requires processing in the liver before it goes to the rest of the body. That processing changes the oral medication into something else, a by-product not recognized as the youthful estrogen your body likes: estradiol. Transdermal creams bypass the liver.

Objectively, HRT is the best way to protect bones. Osteoporosis treatment is only second-best because while it increases the density of bones, it makes them very brittle. Its a different architecture.

Meanwhile, women continue to come to us every day, completely confused and even scared about hormone replacement. We have always been dedicated to clearing up misconceptions about hormone replacement therapy, and . providing women with alternatives to conventional hormone replacement, including bio-identical hormones Because there havent been many definitive studies done on bioidentical hormone replacement therapy, we do not know exactly what the risks are for every woman taking it. What we do know is that from the results of studies that have looked at bio-identical hormone replacement therapy, and from what has been seen in the clinical practice of prescribing bio-identical hormone replacement to patients, bio-identical hormone replacement therapy does not appear to have the same side effects consistent with conventional hormone replacement therapy, in particular transdermal forms.

Bio-identical hormones have been shown to share the exact same molecular structure with those found in our bodies. Unlike conventional or synthetic forms of hormone replacement therapy, they are not patented and sold by pharmaceutical companies. That is the main reason why there have been very few studies to evaluate their risks and benefits. Bio-identical hormones are not as profitable as the conventional synthetic forms. In the future, more studies will be done to help clarify the benefits or disadvantages associated with bio-identical hormone replacement therapy.

There has have been serious efforts made to shut down compounded bio-identical hormone replacement therapy as an option for women. The belief of our office is that women deserve to know all of their options and alternatives surrounding hormone replacement therapy. They need to be fully informed of everything we have learned and have access to these options when they need them.

In order to find answers to your questions about bio-identical hormone replacement therapy and how to decide if that could be a better choice for you, please call our office at (314) 292-7080 to set up a consultation with one of practitioners. We here at Womens Health Specialists of St. Louis are dedicated to your complete healthcare needs. Educating yourself as much as possible will always lead you to better health. Being informed is the only way you can decide the right decision for yourself.

Follow this link:
Hormone Replacement Therapy - Teresa knight

Posted in Hormone Replacement Therapy | Comments Off on Hormone Replacement Therapy – Teresa knight

Bioidentical Hormone Replacement Therapy | Menopause Doctor …

Posted: October 22, 2016 at 6:43 pm

RejuvinAge, a Virginia Beach Bioidentical Hormone Replacement Center, focuses on Individualizing Hormone Therapy for Women and Men. RejuvinAge specializes in Hormone Replacement for approved indications of Menopause for women and Low Testosterone Replacement Therapy for men.

Women and men are very comfortable and confident in our boutique setting for hormone replacement. Programs are individualized; one size does not fit all. Every program is physician managed; appointments are always on time with our hormone replacement doctor, Jennifer Krup, M.D. Personalized care is our focus; we recognize the importance of one on one attention.

Focusing on menopause for women, Dr. Krup encourages every woman to embrace this phase of their life.Understanding BHRT empowers women with the knowledge to make the right decisions and successfully manage menopausal symptoms. Understanding appropriate dosages, appropriate routes of administration and the appropriate length of treatment for each woman keeps RejuvinAge in the forefront

Offering Low T options for men, Dr. Krup will help determine ifTestosterone Replacement Therapyis right for you. Making the right choice for TRT is an important decision for men today.

The RejuvinAge approach to Bio Identical Hormone Replacement for women and men is based on sound medicine. Hormone optimization takes patience, compliance, great communication and a partnership with you. Our Virginia Beach Hormone Replacement center is easily accessible to the surrounding cities of Norfolk, Chesapeake, Hampton Newport News, Williamsburg and beyond. Make your appointment today-meet Dr. Krup in her Virginia BeachBio-Identical Hormone Center.

Link:
Bioidentical Hormone Replacement Therapy | Menopause Doctor ...

Posted in Hormone Replacement Therapy | Comments Off on Bioidentical Hormone Replacement Therapy | Menopause Doctor …

Rhode Island Hospital Unveils New COBRE Center for Stem …

Posted: October 22, 2016 at 6:41 pm

3/27/2013

Current stem cell studies include research into new treatments for leukemia, lymphoma and liver, kidney and bone marrow damage

Rhode Island Hospital is expanding its research space in the citys bio-med-focused Knowledge District with the opening of a new hematology-oncology laboratory, the COBRE Center for Stem Cell Biology. The lab, which is located in Lifespans research hub the Coro Building -- provides researchers with the state-of-the-art technology needed to support ongoing research in the areas of cancer, tissue injury and basic stem cell biology.

The new 11,000-square-foot hematology-oncology research lab was made possible by a grant from the National Institutes of Health (NIH). The NIH conferred more than $300,000 to Peter Quesenberry, MD, director of hematology oncology at Rhode Island and The Miriam hospitals, specifically for the construction of the new lab.

This new lab space will help us to further study the use of stem cells for the treatment of many illnesses various forms of cancer, tissue and organ damage and much more, Quesenberry said. Creating this research hub provides our researchers with the best possible resources, and places us in close proximity to the hospitals, allowing us to more appropriately collaborate with our peers, and truly bring research from the bench to the bedside.

Quesenberry continued, Additionally, by working closely with the physicians, we are developing new studies that stem from the patient essentially, creating research in reverse, from the bedside to the bench, in an effort to develop new treatments for all-too-common and debilitating illnesses.

The cancer studies being conducted are directed toward revising drug resistance in prostate cancer, chronic myelocytic leukemia and breast cancer. Additionally, cutting-edge studies to develop better treatments for prostate and breast cancer are being conducted, as are studies of mesenchymal stem cells for their ability to reverse pulmonary hypertension. The laboratory also will support research in novel anti-cancer treatments for pediatric and adult malignancies, and will continue to examine therapeutic mechanisms underlying refractory leukemia and lymphoma. The new lab space can accommodate 14 laboratory benches, and can accommodate 10 funded investigators, as well as their technicians and students.

Part of Rhode Island Hospitals mission is to be at the forefront of patient care by creating, applying and sharing the most advanced knowledge in health care, said Peter Snyder, PhD, senior vice president and chief research officer for Lifespan.. One of the ways we do that is by providing our researchers with the tools they need to conduct cutting-edge research in order to discover and create improved diagnostic measures and treatments. This new research space is the first step in a major renovation project at the Coro Building that we believe will serve as a focal point for clinical research in Rhode Island, and propel us to the forefront of academic medicine in the U.S.

More here:
Rhode Island Hospital Unveils New COBRE Center for Stem ...

Posted in Rhode Island Stem Cells | Comments Off on Rhode Island Hospital Unveils New COBRE Center for Stem …

Page 1,662«..1020..1,6611,6621,6631,664..1,6701,680..»